The emerging approach of the medication represents a exciting breakthrough in the management of type 2 diabetes. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide291591.boyblogguide.com/40645633/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment